Awareness of polycystic ovary syndrome among obstetrician-gynecologists and endocrinologists in Northern Europe
Autor: | Melanie Gibson-Helm, Angelica Lindén Hirschberg, Riikka K Arffman, Maria Ruokojärvi, Pernille Ravn, Linda Kujanpää, Thora Steingrimsdottir, Juha S. Tapanainen, Terhi Piltonen, Eszter Vanky, Laure Morin-Papunen, Marianne Andersen, Kobra Falah-Hassani, Elisabet Stener-Victorin, Helena J. Teede, Helle Karro, Dorte Glintborg, Inger Sundrström-Poromaa, Jan Roar Mellembakken |
---|---|
Přispěvatelé: | Læknadeild (HÍ), Faculty of Medicine (UI), Heilbrigðisvísindasvið (HÍ), School of Health Sciences (UI), Háskóli Íslands, University of Iceland, HUS Gynecology and Obstetrics, Reproductive Disease Modeling, Clinicum, Department of Obstetrics and Gynecology, University of Helsinki |
Rok vydání: | 2019 |
Předmět: |
Male
Medical Doctors Cross-sectional study Physiology Health Care Providers Iceland 111402 Obstetrics and Gynaecology Comorbidity Geographical locations 0302 clinical medicine Endocrinology 3123 Gynaecology and paediatrics Surveys and Questionnaires Health care PCOS Medicine and Health Sciences Medical Personnel 030219 obstetrics & reproductive medicine Multidisciplinary Middle Aged Polycystic ovary female genital diseases and pregnancy complications Metformin 3. Good health Lifestyle management Europe Professions Nordic countries Endocrinologists Oncology Health Education and Awareness Medicine Regression Analysis Female Psychosocial Polycystic Ovary Syndrome Research Article Adult Estonia medicine.medical_specialty Science 030209 endocrinology & metabolism Reproduktionsmedicin och gynekologi 03 medical and health sciences Obstetrics Gynecology and Reproductive Medicine Physicians medicine Humans Reproductive Endocrinology VDP::Medisinske Fag: 700 European Union Life Style Fjölblöðrueggjastokkaheilkenni Psychological and Psychosocial Issues Endocrine Physiology business.industry FOS: Clinical medicine Cancers and Neoplasms Biology and Life Sciences Odds ratio Guideline medicine.disease VDP::Medical disciplines: 700 Psychotherapy Health Care Cross-Sectional Studies Family medicine People and Places Population Groupings business Gynecological Tumors Contraceptives Oral |
Zdroj: | PLoS ONE PLoS ONE, Vol 14, Iss 12, p e0226074 (2019) PLOS ONE Piltonen, T T, Ruokojärvi, M, Karro, H, Kujanpää, L, Morin-Papunen, L, Tapanainen, J S, Stener-Victorin, E, Sundrström-Poromaa, I, Hirschberg, A L, Ravn, P, Glintborg, D, Mellembakken, J R, Steingrimsdottir, T, Gibson-Helm, M, Vanky, E, Andersen, M, Arffman, R K, Teede, H & Falah-Hassani, K 2019, ' Awareness of polycystic ovary syndrome among obstetrician-gynecologists and endocrinologists in Northern Europe ', PLOS ONE, vol. 14, no. 12, e0226074 . https://doi.org/10.1371/journal.pone.0226074 |
ISSN: | 1932-6203 |
DOI: | 10.1371/journal.pone.0226074 |
Popis: | Publisher's version (útgefin grein) Objective: To date, little is known about differences in the knowledge, diagnosis making and treatment strategies of health care providers regarding polycystic ovary syndrome (PCOS) across different disciplines in countries with similar health care systems. To inform guideline translation, we aimed to study physician reported awareness, diagnosis and management of PCOS and to explore differences between medical disciplines in the Nordic countries and Estonia. Methods: This cross-sectional survey was conducted among 382 endocrinologists and obstetrician-gynaecologists in the Nordic countries and Estonia in 2015–2016. Of the participating physicians, 43% resided in Finland, 18% in Denmark, 16% in Norway, 13% in Estonia, and 10% in Sweden or Iceland, and 75% were obstetrician-gynaecologists. Multivariable logistic regression models were run to identify health care provider characteristics for awareness, diagnosis and treatment of PCOS. Results: Clinical features, lifestyle management and comorbidity were commonly recognized in women with PCOS, while impairment in psychosocial wellbeing was not well acknowledged. Over two-thirds of the physicians used the Rotterdam diagnostic criteria for PCOS. Medical endocrinologists more often recommended lifestyle management (OR = 3.6, CI 1.6–8.1) or metformin (OR = 5.0, CI 2.5–10.2), but less frequently OCP (OR = 0.5, CI 0.2–0.9) for non-fertility concerns than general obstetrician-gynaecologists. The physicians aged 56 (adjusted odds ratio (OR) = 0.4, 95% CI 0.2–0.8). Conclusion: Despite well-organized healthcare, awareness, diagnosis and management of PCOS is suboptimal, especially in relation to psychosocial comorbidities, among physicians in the Nordic countries and Estonia. Physicians need more education on PCOS and evidence-based information on Rotterdam diagnostic criteria, psychosocial features and treatment of PCOS, with the recently published international PCOS guideline well needed and welcomed. This study was supported by the Sigrid Juselius foundation, the Academy of Finland (grant no: 321763) and the Finnish Medical Association. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |